Loading clinical trials...
Loading clinical trials...
Characterization of the Expression and Activity of Inhibitory Receptors Such as CLM-1 in Eosinophils of Atopic Subjects
Conditions
Locations
1
Israel
Meir Medical Center. Unit of Allergy and Clinical Immunology
Kfar Saba, Israel
Start Date
May 1, 2012
Primary Completion Date
December 31, 2013
Completion Date
December 31, 2013
Last Updated
March 22, 2018
NCT02327897
NCT07486401
NCT07219173
NCT07262983
NCT06389136
NCT04706988
Lead Sponsor
Meir Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions